Glutamate attenuates the ILC2 response and allergic airway inflammation via the kainate receptor GluK2
Open Access
- 16 October 2026
- journal article
- research article
- Published by Springer Nature in Cellular & Molecular Immunology
- p. 1-15
Abstract
Group 2 innate lymphoid cells (ILC2s) play a critical role in initiating the type 2 immune response, particularly in allergic airway diseases. Although the effects of glutamate on the immune system have been reported previously, its role in modulating the function of ILC2s and lung inflammation remains unclear. In this study, we report that the glutamate levels increased in lung tissue following exposure to allergens. Consequently, glutamate was found to restrain ILC2 responses during lung inflammation in mice. Using Rag1 −/− mice, we demonstrated that the inhibitory effect of glutamate on type 2 inflammation was independent of T and B cells. Further ILC2 adoptive transfer experiments in Rag −/− Il2rg −/− mice confirmed that glutamate likely exerted its effects by directly targeting ILC2s. In vitro experiments revealed that glutamate suppressed ILC2 function through ionic kainate receptor signaling. Genetic deletion of the kainate receptor subunit GluK2 enhanced ILC2 responses and exacerbated type 2 lung inflammation. Mechanistically, transcriptome and metabolic analyses revealed that glutamate reduced oxidative metabolism in ILC2s, thereby limiting their activation. Consistently, in vivo administration of BPAM344—a positive allosteric modulator that potentiates GluK2 signaling—effectively suppressed allergen-induced type 2 inflammation. Notably, ILC2-specific GluK2 deletion markedly attenuated the anti-inflammatory effects of BPAM344, indicating that its protective effects depend on ILC2-intrinsic GluK2 signaling. These findings demonstrate a novel role for glutamate in restraining ILC2 function, as it plays a protective role in alleviating airway inflammation. We propose that GluK2 activation may offer a promising therapeutic strategy for treating ILC2-driven allergic asthma.Keywords
This publication has 54 references indexed in Scilit:
- The basic immunology of asthmaCell, 2021
- Nonpeptidergic neurons suppress mast cells via glutamate to maintain skin homeostasisCell, 2021
- The basic immunology of asthmaCell, 2021
- A Cold-Sensing Receptor Encoded by a Glutamate Receptor GeneCell, 2019
- Calcium Transport and Signaling in MitochondriaComprehensive Physiology, 2017
- The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cellsJournal of Neural Transmission, 2014
- Glutamate: a truly functional amino acidAmino Acids, 2012
- Activation of V(D)J recombination by RAG1 and RAG2Trends in Genetics, 1992
- The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunitsNeuron, 1992
- Papain-induced asthma—physiological and immunological featuresJournal of Allergy and Clinical Immunology, 1979